🇺🇸 Systemic corticosteroids in United States

19 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Staphylococcal Infection — 3 reports (15.79%)
  2. Cellulitis — 2 reports (10.53%)
  3. Fungal Infection — 2 reports (10.53%)
  4. Intentional Product Use Issue — 2 reports (10.53%)
  5. Klebsiella Infection — 2 reports (10.53%)
  6. Pathogen Resistance — 2 reports (10.53%)
  7. Septic Shock — 2 reports (10.53%)
  8. Skin Infection — 2 reports (10.53%)
  9. Abdominal Abscess — 1 report (5.26%)
  10. Accidental Overdose — 1 report (5.26%)

Source database →

Systemic corticosteroids in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Systemic corticosteroids approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Systemic corticosteroids in United States?

Johannes Trueck is the originator. The local marketing authorisation holder may differ — check the official source linked above.